CARDIOVASCULAR OUTCOMES AND MORTALITY AFTER INITIATION OF CANAGLIFLOZIN VERSUS NON-SGLT2I ANTIHYPERGLYCEMIC AGENTS: ADDITIONAL ANALYSES FROM THE EASEL POPULATION-BASED COHORT STUDY
Udell, Jacob A., Yuan, Zhong, Ryan, Patrick, Rush, Toni, Sicignano, Nicholas M., Galitz, Michael, Rosenthal, NormanVolume:
73
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/S0735-1097(19)32386-1
Date:
March, 2019
Fichier:
PDF, 224 KB
2019